Atrial Natriuretic Peptide in Acute Renal Failure

Critical Care Nephrology, Second Edition

Volumn , Issue , 2008, Pages 429-433

  Ricksten, Sven Erik ^a,b   Swärd, Kristina ^a,b  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 80052069867     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-4252-5.50083-6     Document Type: Chapter

References (35)

1. B Kisch (1956) Electron microscopy of the atrium of the heart. I. Guinea pig. Exp Med Surg 14 99-112.
2. JP Henry, OH Gauer and JL Reeves (1956) Evidence of the atrial location of receptors influencing urine flow. Circ Res 4 85-90.
3. JD Jamieson and GE Palade (1964) Specific granules in atrial muscle cells. J Cell Biol 23 151-172.
4. AJ de Bold, HB Borenstein, AT Veress and H Sonnenberg (1981) A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. Life Sci 28 89-94.
5. TG Flynn, ML de Bold and AJ de Bold (1983) The amino acid sequence of an atrial peptide with potent diuretic and natriuretic properties. Biochem Biophys Res Commun 117 859-865.
6. K Kangawa and H Matsuo (1984) Purification and complete amino acid sequence of alpha-human atrial natriuretic polypeptide (alpha-hANP). Biochem Biophys Res Commun 118 131-139.
7. BM Brenner, BJ Ballermann, ME Gunning and ML Zeidel (1990) Diverse biological actions of atrial natriuretic peptide. Physiol Rev 70 665-699.
8. P Weidmann, L Hasler, MP Gnadinger, et al. (1986) Blood levels and renal effects of atrial natriuretic peptide in normal man. J Clin Invest 77 734-742.
9. J Biollaz, J Nussberger, M Porchet, et al. (1986) Four-hour infusions of synthetic atrial natriuretic peptide in normal volunteers. Hypertension 8 II96-II105.
10. J Bidiville, G Waeber, M Porchet, et al. (1988) Hemodynamic, renal and endocrine effects of 4-hour infusions of human atrial natriuretic peptide in normal volunteers. Fundam Clin Pharmacol 2 413-429.
11. WM Janssen, D de Zeeuw, GK van der Hem and PE de Jong (1989) Atrial natriuretic peptide–induced decreases in renal blood flow in man: Implications for the natriuretic mechanism. Clin Sci 77 55-60.
12. F Valsson, SE Ricksten, T Hedner, et al. (1994) Effects of atrial natriuretic peptide on renal function after cardiac surgery and in cyclosporine-treated heart transplant recipients. J Cardiothorac Vasc Anesth 8 425-430.
13. A Bergman, I Odar-Cederlof, E Theodorsson and L Westman (1994) Renal effects of human atrial natriuretic peptide in patients after major vascular surgery. Acta Anaesthesiol Scand 38 667-671.
14. K Swärd, F Valsson, J Sellgren and SE Ricksten (2005) Differential effects of human atrial natriuretic peptide and furosemide on glomerular filtration rate and renal oxygen consumption in humans. Intensive Care Med 31 79-85.
15. M Marin-Grez, JT Fleming and M Steinhausen (1986) Atrial natriuretic peptide causes pre-glomerular vasodilatation and post-glomerular vasoconstriction in rat kidney. Nature 324 473-476.
16. NA Lassen, O Munck and JH Thaysen (1961) Oxygen consumption and sodium reabsorption in the kidney. Acta Physiol Scand 51 371-384.
17. ML Zeidel, JL Seifter, S Lear, BM Brenner and P Silva (1986) Atrial peptides inhibit oxygen consumption in kidney medullary collecting duct cells. Am J Physiol 251 F379-F383.
18. A Gadano, R Moreau, F Vachiery, et al. (1997) Natriuretic response to the combination of atrial natriuretic peptide and terlipressin in patients with cirrhosis and refractory ascites. J Hepatol 26 1229-1234.
19. CM Mangano, LS Diamondstone, JG Ramsay, et al. (1998) Renal dysfunction after myocardial revascularization: Risk factors, adverse outcomes, and hospital resource utilization. The Multicenter Study of Perioperative Ischemia Research Group. Ann Intern Med 128 194-203.
20. M Brezis and S Rosen (1995) Hypoxia of the renal medulla—its implications for disease. N Engl J Med 332 647-655.
21. CA Block and HL Manning (2002) Prevention of acute renal failure in the critically ill. Am J Respir Crit Care Med 165 320-324.
22. K Schafferhans, E Heidbreder, D Grimm and A Heidland (1986) Human atrial natriuretic factor prevents against norepinephrine-induced acute renal failure in the rat. Klin Wochenschr 64(Suppl 6), 73-77.
23. JD Conger, SA Falk, BH Yuan and RW Schrier (1989) Atrial natriuretic peptide and dopamine in a rat model of ischemic acute renal failure. Kidney Int 35 1126-1132.
24. C Mitaka, Y Hirata, K Habuka, et al. (2003) Atrial natriuretic peptide infusion improves ischemic renal failure after suprarenal abdominal aortic cross-clamping in dogs. Crit Care Med 31 2205-2210.
25. SN Rahman, GE Kim, AS Mathew, et al. (1994) Effects of atrial natriuretic peptide in clinical acute renal failure. Kidney Int 45 1731-1738.
26. F Valsson, SE Ricksten, T Hedner and S Lundin (1996) Effects of atrial natriuretic peptide on acute renal impairment in patients with heart failure after cardiac surgery. Intensive Care Med 22 230-236.
27. K Swärd, F Valsson and SE Ricksten (2001) Long-term infusion of atrial natriuretic peptide (ANP) improves renal blood flow and glomerular filtration rate in clinical acute renal failure. Acta Anaesthesiol Scand 45 536-542.
28. C Ichai, J Soubielle, M Carles, et al. (2000) Comparison of the renal effects of low to high doses of dopamine and dobutamine in critically ill patients: A single-blind randomized study. Crit Care Med 28 921-928.
29. RL Allgren, TC Marbury, SN Rahman, et al. (1997) Anaritide in acute tubular necrosis. Auriculin Anaritide Acute Renal Failure Study Group. N Engl J Med 336 828-834.
30. J Lewis, MM Salem, GM Chertow, et al. (2000) Atrial natriuretic factor in oliguric acute renal failure. Anaritide Acute Renal Failure Study Group. Am J Kidney Dis 36 767-774.
31. JD Conger, MF Schultz, F Miller, et al. (1994) Responses to hemorrhagic arterial pressure reduction in different ischemic renal failure models. Kidney Int 46 318-323.
32. K Swärd, F Valsson, P Odencrants, et al. (2004) Recombinant human atrial natriuretic peptide in ischemic acute renal failure: A randomized placebo-controlled trial. Crit Care Med 32 1310-1315.
33. JM Hansen, N Fogh-Andersen, NJ Christensen and S Strandgaard (1997) Cyclosporine-induced hypertension and decline in renal function in healthy volunteers. J Hypertens 15 319-326.
34. N Akamatsu, Y Sugawara, S Tamura, et al. (2005) Prevention of renal impairment by continuous infusion of human atrial natriuretic peptide after liver transplantation. Transplantation 80 1093-1098.
35. BR Kurnik, RL Allgren, FC Genter, et al. (1998) Prospective study of atrial natriuretic peptide for the prevention of radiocontrast-induced nephropathy. Am J Kidney Dis 31 674-680.